chemiluminescence 10 and spectrophotometric 11 methods have been reported for estimating OR alone as well as in combinations. In this study, a simple, rapid, accurate and sensitive method was developed for estimating GT and OR in tablet formulations.
Experimental

Reagents
Gatifloxacin and ornidazole working standards were procured as gift samples from M/S Sun Pharmaceutical Pvt. Ltd., Vapi, India. Silica gel 60 F254 TLC plates (20 × 20 cm, layer thickness 0.2 mm, E. Merck, Germany) were used as a stationary phase. n-Butanol, ammonia (6 M) and methanol (A. R., Ranbaxy Ltd., New Delhi) were used for mobile-phase preparation and as solvents.
A commercially available combined tablet formulation of GT (200/400 mg) and OR (500/1000 mg) was procured from the local market.
Apparatus
A Camag HPTLC system (Switzerland) comprising a Camag Linomat IV semiautomatic sample applicator, a Camag TLC Scanner 3, a Camag twin-trough chamber (10 × 10 cm), Camag CATS 4 software, a Hamilton syringe (100 µl), a Shimadzu libror AEG-220 weighing balance and a sonicator (Frontline FS-4, Mumbai) was used during the study.
Chromatographic conditions
Chromatographic estimations were performed under the following conditions: stationary phase, precoated silica gel 60 F254 aluminum sheets (20 × 10 cm) (prewashed with methanol, and dried in air); mobile phase, n-butanol:methanol:ammonia (8:1:1.5 v/v); chamber saturation time, 45 min; temperature, 25 ± 2˚C; migration distance, 45 mm; wavelength of detection, 302 nm; and slit dimensions, 4 × 0.1 mm. The following spotting parameters were used: band width, 4 mm; space between 2 bands, 4 mm; and spraying rate, 10 µl.
Preparation of combined standard solution of GT and OR
GT (10 mg) and OR (25 mg) were weighed accurately and transferred in 100 ml volumetric flask. Methanol (25 ml) was added and sonicated for 20 min, and then diluted up to the mark with methanol. The aliquot (2 ml) was further diluted to 10 ml with the same solvent. The final solution contained 20 µg of GT and 50 µg of OR per ml of the solution.
Preparation of calibration curve
Aliquots of 5, 10, 15, 20 and 25 µl of standard solution were spotted on precoated TLC plates, using a semiautomatic spotter under a nitrogen stream. The plate was dried in air and developed for up to 45 mm at constant temperature using a mixture of nbutanol:methanol:ammonia (8:1:1.5 v/v) as the mobile phase in a Camag twin-trough chamber previously saturated with the mobile phase for 45 min. The plate was removed from the chamber and dried in air. Photometric measurements were performed at 302 nm in the absorbance/reflectance mode with the Camag TLC Scanner 3 using CATS 4 software incorporating the track optimization option. The calibration curve was prepared by plotting the peak area versus the concentration (ng/spot) corresponding to each spot.
Procedure for pharmaceutical formulations
Twenty tablets were accurately weighed and finely powdered. The powder equivalent to GT (10 mg) and OR (25 mg) was accurately weighed, mixed with methanol (25 ml) and sonicated for 20 min. The solution was filtered through Whatman filter paper No. 41. The residue was thoroughly washed with methanol. The filtrate and washings were combined in a 100 ml volumetric flask and diluted to the mark with methanol. The filtrate (2 ml) was further diluted to 10 ml with the same solvent. The final test solution contained 20 µg of GT and 50 µg of OR per ml of the solution. Fifteen microliters of the sample solution was applied on a TLC plate under a nitrogen stream using a semiautomatic spotter. The TLC plate was developed and photometrically analyzed as described under the Chromatographic conditions. The amounts of GT and OR present in the sample solution were determined by fitting the area values of peaks corresponding to GT and OR into the equation of the line representing the calibration curve of GT and OR. All determinations were performed in triplicate.
Results and Discussion
GT and OR are soluble in methanol; therefore, methanol was selected as the solvent. The formulation was dissolved in methanol with sonication for 20 min to assure complete release of the drug from the formulation matrix. The mixture of nbutanol:methanol:ammonia (8:1:1.5 v/v) could resolve GT and OR spots with a better peak shape. The combination of nbutanol and methanol offered the optimum migration (Rf values of 0.21 ± 0.02 for GT and 0.76 ± 0.04 for OR) and resolution of GT from other components of the formulation matrix (Fig. 1) . On the other hand, an ammonia solution helped to sharpen the peak. Even saturation of the TLC chamber with the mobile phase for 45 min assured better reproducibility and better resolution.
The linearity of GT and OR were in the range of 100 -500 ng/spot and 250 -1250 ng/spot, respectively, with a correlation coefficient more than 0.9850. The average linear-regression equation was represented as Y = 19.430X + 3220.3 for GT and Y = 12.377X + 3815.5 for OR, where X is the concentration of drug and Y is the peak area. The limit of detection was found to be 40 ng/spot for GT and 100 ng/spot for OR. The limit of quantification was found to be 100 ng/spot for GT and 250 ng/spot for OR. The intra-day precision (RSD) was determined for standard GT (100 -500 ng/spot) and OR (250 -1250 ng/spot) 3 times on the same day. The inter-day precision (RSD) was calculated for standard GT (100 -500 ng/spot) and OR (250 -1250 ng/spot) 5 times over a period of one week. The intra-day and inter-day coefficients of variation for both drugs were found to be in the range of 0.68 -2.58% and 0.37 -3.62%, respectively. These values indicate that the method is precise.
The precision of the instrument was checked by repeated scanning of the same spot (100 ng/spot for GT and 250 ng/spot for OR) of both drugs seven times without changing the position of the plate; the %CV for measuring the peak area was found to be 0.68% for GT and 0.82% for OR. The repeatability of the method was checked by spotting 5 µl of a combined standard solution seven times on the TLC plate (n = 7); the % CV for the peak area was found to be 1.23% for GT and 0.98% for OR. Both the %CV, for measuring the peak area and sample applications (less than 1% and 3%, respectively), ensuring proper functioning of the HPTLC system.
The accuracy of the method was evaluated by calculating the recovery of GT and OR by the standard addition method at 5 levels of the calibration curve (n = 3). The percentage recovery was found to be 98.03 -100.95% for GT and 97.34 -101.88% for OR ensuring that the method is accurate.
The method was found to be specific for GT and OR in 744 ANALYTICAL SCIENCES MAY 2006, VOL. 22 Fig. 1 Chromatogram of gatifloxacin and ornidazole from a tablet formulation. Chromatogram of the sample showing resolution of (a) gatifloxacin peak (300 ng/spot, Rf = 0.21 ± 0.02) and (b) ornidazole (750 ng/spot, Rf = 0.76 ± 0.04) peak from components of the formulation matrix. Fig. 2 Peak purity spectra of gatifloxacin and ornidazole. (a) Peak purity spectra of sample gatifloxacin (100 ng/spot) at peak start, peak apex and peak end. (b) Peak purity spectra of sample ornidazole (250 ng/spot) at peak start, peak apex and peak end.
combined formulations. The purity of the GT and OR peak was determined by comparing the spectra at three different levels i.e. at peak start (S), peak apex (M) and peak end (E). The correlation between these three spectra indicated the purity of GT peak (correlation, r(S, M) = 0.9998, r(M, E) = 0.9964, Fig.  2a ). The correlation between these three spectra indicated the purity of the OR peak (correlation, r(S, M) = 0.9997, r(M, E) = 0.9996, Fig. 2b ). The spectrum of GT and OR extracted from tablet was also compared with the spectrum of the standard GT and OR, which showed a correlation of more than 0.9993. Different validation parameters for the proposed HPTLC method for determining the GT and OR content are summarized in Table 1 . This method was applied to determine the content of GT and OR in two different combined market samples of GT and OR tablets. The content and percentage of GT and OR in two different market samples are presented in Table 2 . The results indicate that the proposed HPTLC method is simple, specific, rapid, precise and accurate for the simultaneously estimation of GT and OR in its combined formulations. Intra day (n = 3) Inter day (n = 5) Repeatability of sample application (n = 7) Repeatability of peak area (n = 7) Recovery, % (n = 3) Limit of detection (ng/spot) Limit of quantification (ng/spot) Specificity The formulation A contains gatifloxacin (200 mg) and ornidazole (500 mg) (Gatri OZ tablets, manufactured by Nicholas Piramal India Limited, Mumbai) and formulation B contains gatifloxacin (400 mg) and ornidazole (1000 mg) (Gatiquin OZ kit tablet, manufactured by Cipla Limited, Mumbai) were purchased from the market.
